News

Two Johns Hopkins research teams have received technology development grants totaling approximately $200,000 through the Louis B. Thalheimer Fund for Translational Research. Finalists pitched their proposals virtually in late May…

A first-of-a-kind database of quantum nanoclusters created by Johns Hopkins materials scientists has the potential to facilitate the development of new technologies ranging from highly efficient catalysts and improved sensors…

One in 10 children in the United States is born prematurely, putting them at risk for a host of health challenges that range from chronic asthma and loss of hearing…

Microplastics are quite literally everywhere: in face creams and moisturizers, toothpaste, car tires, disposable water bottles, food, soil, air, and most notably—in our oceans and waterways. These tiny particles of…

As they tested thick, laminated reactive foils of aluminum, zirconium, and carbon in the lab, Tim Weihs and Shane Arlington noticed some properties that baffled them. Weihs, a professor of…

Crohn’s Disease is an inflammatory bowel disease that affects an estimated 780,000 Americans, with even higher rates reported in Canada and Europe. Among its many complications are perianal fistulas: tunnels…

The findings could better inform treatment options and help prevent severe outcomes of the disease

Metrics also enabled researchers to group participants based on clinical parameters

The method is more environmentally friendly than current mining approaches and can aid in the production of more sustainable energy resources, such as lithium-ion batteries

New Assistant Professors Corey Oses and Dingchang Lin add new dimensions to the Department of Material Science and Engineering

Breakthrough medical technology like mRNA vaccines rely on tiny nanoparticles to deliver medicine to cells. A new device will help drug manufacturers and evaluators like the FDA more precisely measure genetic payloads to evaluate drug effectiveness.

Researchers in the lab of department chair and faculty member Howard Katz have developed a method of identifying and monitoring SARS-Cov-2 (COVID-19) proteins and antibodies in samples using a new…